Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00RGD
|
|||
| Former ID |
DNC009833
|
|||
| Drug Name |
N-hydroxy-8-oxo-8-(pyridin-3-yl)octanamide
|
|||
| Synonyms |
CHEMBL98911; N-hydroxy-8-oxo-8-(pyridin-3-yl)octanamide; SCHEMBL3378753; BDBM50114831; 8-Oxo-8-pyridin-3-yl-octanoic acid hydroxyamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H18N2O3
|
|||
| Canonical SMILES |
C1=CC(=CN=C1)C(=O)CCCCCCC(=O)NO
|
|||
| InChI |
1S/C13H18N2O3/c16-12(11-6-5-9-14-10-11)7-3-1-2-4-8-13(17)15-18/h5-6,9-10,18H,1-4,7-8H2,(H,15,17)
|
|||
| InChIKey |
AAHQDWBMLVLXAC-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment. Eur J Med Chem. 2009 Jul;44(7):2868-76. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.